Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Hiroaki Wakimoto, Ph.D., M.D.

Co-Author

This page shows the publications co-authored by Hiroaki Wakimoto and Ameya Kirtane.
Connection Strength

0.505
  1. Local Targeting of NAD+ Salvage Pathway Alters the Immune Tumor Microenvironment and Enhances Checkpoint Immunotherapy in Glioblastoma. Cancer Res. 2021 Apr 01; 81(7):1922.
    View in: PubMed
    Score: 0.232
  2. Local Targeting of NAD+ Salvage Pathway Alters the Immune Tumor Microenvironment and Enhances Checkpoint Immunotherapy in Glioblastoma. Cancer Res. 2020 11 15; 80(22):5024-5034.
    View in: PubMed
    Score: 0.224
  3. Genotype-targeted local therapy of glioma. Proc Natl Acad Sci U S A. 2018 09 04; 115(36):E8388-E8394.
    View in: PubMed
    Score: 0.048
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.